ACADIA Pharmaceuticals Inc (ACAD)
16.20
-0.08
(-0.46%)
USD |
NASDAQ |
Nov 21, 16:00
16.20
0.00 (0.00%)
After-Hours: 19:53
ACADIA Pharmaceuticals Market Cap: 2.695B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 2.707B |
| November 19, 2024 | 2.697B |
| November 18, 2024 | 2.834B |
| November 15, 2024 | 2.790B |
| November 14, 2024 | 2.832B |
| November 13, 2024 | 2.927B |
| November 12, 2024 | 2.983B |
| November 11, 2024 | 3.040B |
| November 08, 2024 | 2.938B |
| November 07, 2024 | 2.862B |
| November 06, 2024 | 2.627B |
| November 05, 2024 | 2.496B |
| November 04, 2024 | 2.433B |
| November 01, 2024 | 2.464B |
| October 31, 2024 | 2.428B |
| October 30, 2024 | 2.458B |
| October 29, 2024 | 2.453B |
| October 28, 2024 | 2.452B |
| October 25, 2024 | 2.385B |
| October 24, 2024 | 2.409B |
| October 23, 2024 | 2.377B |
| October 22, 2024 | 2.415B |
| October 21, 2024 | 2.455B |
| October 18, 2024 | 2.545B |
| October 17, 2024 | 2.524B |
| Date | Value |
|---|---|
| October 16, 2024 | 2.502B |
| October 15, 2024 | 2.480B |
| October 14, 2024 | 2.494B |
| October 11, 2024 | 2.482B |
| October 10, 2024 | 2.420B |
| October 09, 2024 | 2.427B |
| October 08, 2024 | 2.405B |
| October 07, 2024 | 2.450B |
| October 04, 2024 | 2.512B |
| October 03, 2024 | 2.449B |
| October 02, 2024 | 2.517B |
| October 01, 2024 | 2.545B |
| September 30, 2024 | 2.558B |
| September 27, 2024 | 2.603B |
| September 26, 2024 | 2.568B |
| September 25, 2024 | 2.541B |
| September 24, 2024 | 2.627B |
| September 23, 2024 | 2.702B |
| September 20, 2024 | 2.742B |
| September 19, 2024 | 2.724B |
| September 18, 2024 | 2.709B |
| September 17, 2024 | 2.697B |
| September 16, 2024 | 2.677B |
| September 13, 2024 | 2.707B |
| September 12, 2024 | 2.646B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
2.100B
Minimum
Jun 21 2022
9.028B
Maximum
Dec 01 2020
4.329B
Average
3.651B
Median
Market Cap Benchmarks
| Bristol-Myers Squibb Co | 118.12B |
| NovaBay Pharmaceuticals Inc | 3.508M |
| Palatin Technologies Inc | 17.79M |
| iBio Inc | 22.42M |
| Theriva Biologics Inc | 3.561M |
Market Cap Related Metrics
| PE Ratio | 20.76 |
| PS Ratio | 2.892 |
| Price to Book Value | 4.669 |
| Price to Free Cash Flow | 13.26 |
| Price | 16.20 |
| Earnings Yield | 4.82% |
| Operating PE Ratio | 23.95 |
| Normalized PE Ratio | 20.76 |